These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 29492965
41. The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases. Urano M, Hirai H, Tada Y, Kawakita D, Shimura T, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Fushimi C, Shimizu A, Takase S, Okada T, Sato H, Imanishi Y, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Sato Y, Saigusa N, Nakaguro M, Hanazawa T, Nagao T. Histopathology; 2018 Dec; 73(6):943-952. PubMed ID: 29993139 [Abstract] [Full Text] [Related]
42. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas. Yang RK, Zhao P, Lu C, Luo J, Hu R. Hum Pathol; 2019 Feb; 84():173-182. PubMed ID: 30267779 [Abstract] [Full Text] [Related]
43. Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified. Sousa LG, Wang K, Torman D, Binks BJ, Rubin ML, Andersen CR, Lewis WE, Rivera MJ, Kaya D, El-Naggar AK, Hanna EY, Esmaeli B, Frank SJ, Bell D, Glisson BS, Rodon J, Meric-Bernstam F, Lee JJ, Ferrarotto R. Cancer; 2022 Feb 01; 128(3):509-518. PubMed ID: 34661906 [Abstract] [Full Text] [Related]
44. Primary salivary duct carcinoma arising from the Stensen duct. Noda K, Hirano T, Okamoto T, Suzuki M. Ear Nose Throat J; 2016 Sep 01; 95(9):E15-7. PubMed ID: 27657321 [Abstract] [Full Text] [Related]
45. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. Clin Cancer Res; 2014 Dec 15; 20(24):6570-81. PubMed ID: 25316813 [Abstract] [Full Text] [Related]
46. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. Kassem L, Deygas M, Fattet L, Lopez J, Goulvent T, Lavergne E, Chabaud S, Carrabin N, Chopin N, Bachelot T, Gillet G, Treilleux I, Rimokh R. BMC Cancer; 2015 Jun 04; 15():453. PubMed ID: 26040677 [Abstract] [Full Text] [Related]
49. Brain metastases in patients with salivary duct carcinoma: A retrospective study. Fushimi C, Takahashi H, Kawakita D, Kano S, Tsukahara K, Ozawa H, Okami K, Sakai A, Yamazaki K, Okada T, Hanazawa T, Sato Y, Imanishi Y, Shimizu A, Matsuki T, Nagao T, Tada Y. Cancer Med; 2024 Mar 04; 13(5):e7037. PubMed ID: 38477487 [Abstract] [Full Text] [Related]
50. Salivary duct carcinoma: a Danish national study. Breinholt H, Elhakim MT, Godballe C, Andersen LJ, Primdahl H, Kristensen CA, Bjørndal K. J Oral Pathol Med; 2016 Oct 04; 45(9):664-671. PubMed ID: 26822194 [Abstract] [Full Text] [Related]
52. [Clinicopathological analysis of 40 cases of salivary duct carcinoma]. Lin N, Cai JH, Xu MJ, Kang P, Cheng ZF, He W. Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Jun 09; 54(6):416-419. PubMed ID: 31177683 [Abstract] [Full Text] [Related]
59. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q. Zhonghua Zhong Liu Za Zhi; 2013 Mar 09; 35(3):207-11. PubMed ID: 23880002 [Abstract] [Full Text] [Related]